Author | Theodore H. Welling MD | OncLive

Author | Theodore H. Welling MD

Articles

Dr. Welling on SIRT in Patients With Hepatobiliary Neoplasms

May 01, 2018

Video

Theodore H. Welling MD, associate professor, department of Surgery, director, Liver Tumor Program, NYU Langone’s Perlmutter Cancer Center, discusses the use of selective internal radiation therapy (SIRT) in patients with hepatobiliary cancers.

Dr. Welling on the Efficacy of Nivolumab in HCC

October 04, 2017

Video

Theodore H. Welling, MD, associate professor of surgery, director of the Liver Tumor Program at Perlmutter Cancer Center of NYU Langone Medical Center, discusses the efficacy of nivolumab (Opdivo) for patients with hepatocellular carcinoma (HCC).

Dr. Welling on CheckMate-040 Trial of Nivolumab in HCC

September 17, 2017

Video

Theodore H. Welling, MD, associate professor of surgery, director of the Liver Tumor Program at Perlmutter Cancer Center of NYU Langone Medical Center, discusses the purpose of the CheckMate-040 trial, which explored nivolumab (Opdivo) in patients with hepatocellular carcinoma. (HCC).

Dr. Welling on Incorporating Immunotherapy Into HCC Paradigm

September 16, 2017

Video

Theodore H. Welling, MD, associate professor of surgery, director of the Liver Tumor Program at Perlmutter Cancer Center of NYU Langone Medical Center, discusses how immunotherapy agents will eventually fit into the paradigm of hepatocellular carcinoma. (HCC).

x